FFAR2 and inflammatory bowel disease: It is well established that T cells are involved in the pathogenesis of IBD, and for this reason, we tested the effects of SCFA and GPR43 agonists on human T cell proliferation and cytokine production in a one-way mixed lymphocyte reaction.